系统外围T细胞淋巴瘤的护理模式和临床结果:LEO-MER前性队列研究
Jia Ruan1, Zhengming Chen1, Melissa C Larson2
1Weill Cornell Medicine, New York, New York, United States.
Blood advances
|February 18, 2026
概括
这项研究分析了720名患有外围T细胞淋巴瘤 (PTCL) 的患者的一线护理,发现基于CHOP的治疗方案很常见,但突出了未满足的需求. 对于非ALCL亚型和早期治疗失败的患者,结果更糟糕,这表明需要新的治疗方法.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床试验 临床试验
背景情况:
- 关于当代外围T细胞淋巴瘤 (PTCL) 实践的前性基准研究有限.
- 了解现实世界的一线护理模式和结果对于改善患者生存至关重要.
研究的目的:
- 描述当代的第一线治疗模式和系统性PTCL的结果.
- 确定与PTCL患者的生存相关的临床和治疗因素.
- 突出在PTCL管理中未得到满足的需求领域.
主要方法:
- 分析了来自两个前性队列研究 (LEO和MER) 的720名患者.
- 主要终点:使用卡普兰-梅尔和考克斯回归的无事件生存率 (EFS) 和整体生存率 (OS).
- 二级终点:临床和治疗因素与生存的相关性.
主要成果:
- 基于CHOP的疗法是最常见的 (70%),包括CHOP,CHOP加ETOPOSIDE,以及使用新药 (例如BV-CHP) 的CHOP类疗法.
- 整合性自身干细胞移植在14%的患者中使用.
- 更高的IPI,PIT得分和非ALCL亚型与不良EFS和OS相关.
- 在ALCL中添加埃托向CHOP改善了ALK阴性ALCL的OS;BV-CHP显示了在ALCL中改善OS的趋势.
- 失败EFS6和EFS24的患者在随后的5年内有明显较差的生存状况 (分别为12%和17%).
结论:
- 基于CHOP的诱导仍然是标准的,但与特定PTCL亚型的劣质结果和早期治疗失败有关.
- 该研究确定了PTCL管理的重大未满足需求,特别是非ALCL亚型.
- 优先考虑针对性治疗的临床试验对于改善PTCL患者的治疗结果至关重要.
更多相关视频
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
22.6K
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
774
相关概念视频
Primary Lymphoid Organs
16.1K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
16.1K
Secondary Lymphoid Organs
9.7K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
9.7K
Lymphoid Cells and Tissues
3.4K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
3.4K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Development of the Lymphatic System
2.2K
The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
2.2K
